News
VF Announces 2018 V-RED Awardees
The Vasculitis Foundation is pleased to announce Dr. Linda Brady, a pediatrician with Vanderbilt, is the winner of its 2018 Recognizing Excellence in Diagnostics (V-RED) Award. The award is presented annually to more »
Read More
24-Hour Twitter Event
Vasculitis Awareness Month 2018: Making the Invisible Visible May is Vasculitis Awareness Month and we would like to help spread awareness about the patient experience. Ever wish others understood what more »
Read More
VF Celebrates Vasculitis Awareness Month 2018
The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort more »
Read More
VF Funds $160,000 in New Research
The VF Board of Directors is pleased to announce it has selected three new research studies for funding in 2018. The studies were chosen from a selection of 20 applications more »
Read More
Nucala Approved for EGPA/CSS Treatment
GlaxoSmithKline (GSK) achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US December 13, 2017: GSK announced that the US Food and more »
Read More
#GivingTuesday Matching Gift Challenge
#GivingTuesday is a global day of giving fueled by the power of social media and collaboration. This year your donation can go even further with our generous matching gift challenge! more »
Read More
Introducing our 2017-2018 VCRC-VF Fellow
Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship. She received her medical degree from New York Medical College in Valhalla, New York. She completed her Internal Medicine more »
Read More
Brandon’s Book Released – Going the Distance
Brandon Hudgins, professional long-distance runner, GPA/Wegener’s patient and leader of VF Team Brandon, has shared his story in his recently released book, “Going the Distance: The Journey of a Vasculitis more »
Read More
FDA Approves Genentech’s Actemra® for Giant Cell Arteritis
Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »
Read More
Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony
On Thursday, May 18, Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award. The VF nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »
Read More